Abcam (ABCZF) Stock Price, News & Analysis

Company Overview

Abcam plc was a life sciences company that developed, manufactured and supplied biological research products to academic, pharmaceutical, biotechnology and clinical research organizations. Its portfolio included research antibodies, recombinant proteins, immunoassays, assay kits, biochemicals and related laboratory tools used to study proteins, cells, disease mechanisms and therapeutic targets.

Founded in 1998 and headquartered in Cambridge, England, Abcam built an international business serving researchers in North America, Europe, Asia and other global markets. The company distributed products through online channels, direct sales and research partnerships, supporting applications in areas such as cancer, neuroscience, immunology, cell biology and infectious disease research.

Abcam was acquired by Danaher Corporation in 2023 and subsequently operated as part of Danaher's life sciences portfolio. Before the acquisition, the company was publicly listed in the United Kingdom and its securities also traded in the over-the-counter market in the United States.

Key Stats

• Today's Range: C$22.25 to C$22.25
• 50-Day Range: C$22.25 to C$22.25
• 52-Week Range: C$5.00 to C$23.80
• Volume: N/A
• Average Volume: 2,659 shs
• Market Capitalization: N/A
• P/E Ratio: 130.73
• Dividend Yield: 0.32%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ABCZF
• CIK: 1492074
• Web: abcam.com
• Phone: 441223696000
• Fax: N/A
• Employees: 1,750
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 130.73
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A